Idrx Funding & Investors
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022.
idrx.comTotal Amount Raised: $242,000,000
Idrx Funding Rounds
Series B
$120,000,000
Series B Investors
BlackstoneCommodore CapitalRa Capital ManagementForge Life Science PartnersNick LydonCasdin CapitalAndreessen HorowitzNextech InvestMerck KGaA Darmstadt GermanySeries A
$122,000,000
Series A Investors
Andreessen HorowitzCasdin CapitalNextech InvestForge Life Science Partners
Funding info provided by Diffbot.